Clinical Trial Update: Pharmacokinetics of Thymoglobulin in Paediatric Haematopoietic Stem-cell Transplants [Phase 2]

View source ↗

Summary

Phase 2 trial updating pharmacokinetics of Thymoglobulin in pediatric hematopoietic stem-cell transplants; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Genetic Disorder
• Malignancy
• Metabolic Disease

Drugs mentioned

• Thymoglobulin (rabbit anti-thymocyte globulin)

Snippet

Sponsor: The Hospital for Sick Children | Conditions: Malignancy, Metabolic Disease | Phase 2 | Status: TERMINATED | Results posted: 2019-11-04